| |
| home about contact links |
| |
November 05, 2007UK's Bad MedicineIn the New York Post today, Dr. David Gratzer responds to his critics and points out that the latest data, from an unbiased source, supports his argument that U.S. patients with prostate cancer fare better than their counterparts in the U.K. However, newer studies show a similar trend: Americans do better when diagnosed with cancer than their European counterparts. Since the publication of my City Journal essay, the prestigious journal Lancet Oncology has released a landmark study on cancer-survival rates. Its findings: * The American five-year survival rate for prostate cancer is 99 percent, the European average is 78 percent, and the Scottish and Welsh rates are close to 71 percent. (British data were incomplete.) * For the 16 types of cancer examined in the study, American men have a five-year survival rate of 66 percent, compared with only 47 percent for European men. Among European countries, only Sweden has an overall survival rate for men of more than 60 percent. * American women have a 63 percent chance of living at least five years after a cancer diagnosis, compared with 56 percent for European women. For women, only five European countries have an overall survival rate of more than 60 percent. These data, recently released, are now the best available. They too confirm Giuliani's point: He was fortunate to be treated here.
Posted by Paul Howard at November 5, 2007 09:55 AM CommentsPost a comment |
|
 | ||
| home spotlight commentary research events news about contact links archives | ||
